Please login to the form below

Not currently logged in

MSD’s Keytruda to be made available in England for advanced cervical cancer patients


Around 2,600 people are diagnosed with cervical cancer each year in England

Boehringer Ingelheim and Covant to collaborate on cancer immunotherapies

Boehringer Ingelheim officeThe deal to develop a small-molecule inhibitor could be worth over $480m

Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility

Eli Lilly new HQThe biologics manufacturing site is expected to create more than 300 highly skilled jobs

Regeneron and Sonoma Biotherapeutics partner on autoimmune disease therapies

RegeneronSonoma will receive $75m upfront and will be eligible for a $45m milestone payment

PMGroup announces launch of new recruitment platform PharmaRole

The platform makes it easy to find and apply for jobs in the pharmaceutical and life sciences industry

Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer

Merck & Co HQIt is estimated there will be around 66,000 new cases of uterine cancer in the US this year

BioNTech reveals plans to spend about €1bn more on research and development this year

BiontechThe company has already started clinical trials assessing four new infectious disease vaccines

AstraZeneca’s mild combination asthma reliever approved in UK

AZ NEWOver two and a half million adults with mild cases of asthma could be eligible for the treatment

FDA proposes improvements for oncology clinical trials supporting accelerated approval

The draft guidance discusses the advantage of randomised clinical trials over single-arm studies

Claire GillisQ&A: Claire Gillis

PME interviews VMLY&Rx's CEO

Latest appointments

Subscribe to our email news alerts


Add my company
dna Communications

Because health means everything...

Latest intelligence

Improving cardiovascular disease care and awareness
Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
Humancomms for humancare?
Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...